Prednisolone
Formulations: - Local > Ophthalmological > Solution (eye drops): 0.5% (sodium phosphate) Indications: - Scleritis - Anterior uveitis Source: EML workbook import
MOQ: 1
Price on request
New Arrivals
Fresh additions to the Afya Chain catalogue, ready for discovery and procurement.
New Arrivals (Showing 588 out of 662)
Prednisone
Formulations: - Oral > Solid > tablet: 1 mg Indications: - Adrenocortical insufficiency - Allergic or hypersensitivity conditions of unspecified type - Follicular lymphoma - Lymphoid leukaemia, not elsewhere classified - Diffuse large B-cell lymphoma, not otherwise specified - Chronic lymphocytic leukaemia or small lymphocytic lymphoma - Hodgkin lymphoma - Plasma cell myeloma - Malignant neoplasms of prostate - Anaplastic large cell lymphoma, ALK-negative - Anaplastic large cell lymphoma, ALK-positive - Langerhans cell histiocytosis Source: EML workbook import
MOQ: 1
Price on request
Benznidazole
Formulations: - Oral > Solid > tablet: 100 mg (scored); 50 mg (scored); 12.5 mg Indications: - Chagas disease Source: EML workbook import
MOQ: 1
Price on request
Nifurtimox
Formulations: - Oral > Solid > tablet: 30 mg (scored); 120 mg (scored) Indications: - Chagas disease - Gambiense trypanosomiasis Source: EML workbook import
MOQ: 1
Price on request
Testosterone
Formulations: - Parenteral > General injections > IM: 200 mg per mL in 1 mL ampoule (enantate) Indications: - Testicular dysfunction or testosterone-related disorders Source: EML workbook import
MOQ: 1
Price on request
Cetirizine
Indications: - Allergic or hypersensitivity conditions of unspecified type Source: EML workbook import
MOQ: 1
Price on request
Dexamethasone
Formulations: - Oral > Liquid: 2 mg per 5 mL (as sodium phosphate); 0.5 mg per 5 mL (as sodium phosphate) Parenteral > General injections > unspecified: 4 mg per mL in 1 mL ampoule (dexamethasone phosphate (as sodium phosphate) equialent to 3.3 mg dexamethasone base) Oral > Solid > tablet: 2 mg (as dexamethasone base); 4 mg (as dexamethasone base); 0.5 mg (as dexamethasone base); 0.75 mg (as dexamethasone base); 1.5 mg (as dexamethasone base) Indications: - Palliative care Source: EML workbook import
MOQ: 1
Price on request
Epinephrine
Formulations: - Local > Ophthalmological > Solution (eye drops): 2% (as hydrochloride) Indications: - Primary open-angle glaucoma Source: EML workbook import
MOQ: 1
Price on request
Fexofenadine
Indications: - Allergic or hypersensitivity conditions of unspecified type Source: EML workbook import
MOQ: 1
Price on request
Loratadine
Formulations: - Oral > Liquid: 1 mg per mL Oral > Solid > tablet: 10 mg; 5 mg (chewable); 10 mg (chewable) Indications: - Allergic or hypersensitivity conditions of unspecified type Source: EML workbook import
MOQ: 1
Price on request
Diloxanide
Formulations: - Oral > Solid: 500 mg (furoate) Indications: - Amoebiasis Source: EML workbook import
MOQ: 1
Price on request
Paromomycin
Formulations: - Oral > Liquid: 125 mg per 5 mL as sulfate Oral > Solid: 250 mg as sulfate - Parenteral > General injections > IM: 750 mg paromomycin base (as sulfate) Indications: - Amoebiasis - Visceral leishmaniasis Source: EML workbook import
MOQ: 1
Price on request
Sign Up to Our Newsletter→
Ready to amplify your rewards? Drop your email and we'll be in touch soon.